Comments
Loading...
Pharming (PHAR) Forecast
NewsEarningsPharming (PHAR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPharming (NASDAQ:PHAR) Stock Quotes, Forecast and News Summary
Pharming Stock (NASDAQ: PHAR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pharming (PHAR) stock?
You can purchase shares of Pharming (NASDAQ:PHAR) through any online brokerage.
Who are Pharming (PHAR) competitors?
Other companies in Pharming’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT), Sangamo Therapeutics (NASDAQ:SGMO) and Opthea (NASDAQ:OPT).
What is the forecast, or price target, for Pharming (PHAR) stock?
Pharming has a consensus price target of $27.00.
What is the current price for Pharming (PHAR)?
The stock price for Pharming (NASDAQ: PHAR) is $8.4 last updated December 18, 2024 at 9:13 AM EST.
Does Pharming (PHAR) pay a dividend?
There are no upcoming dividends for Pharming.
When is Pharming (NASDAQ:PHAR) reporting earnings?
Pharming’s Q4 earnings are confirmed for Thursday, March 13, 2025.
Is Pharming (PHAR) going to split?
There is no upcoming split for Pharming.
What sector and industry does Pharming (PHAR) operate in?
Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.